MedTrace Logo

Role of Dietary Fatty Acids in Fatty Liver and Insulin Resistance

NCT01038102 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 65

Last updated 2010-07-13

No results posted yet for this study

Summary

The purpose of this study is to investigate whether substituting saturated fats with polyunsaturated fats reduces fatty liver and improves insulin action and other metabolic variables in abdominally obese subjects

Conditions

Interventions

OTHER

PUFA Diet

Diet high in polyunsaturated (rich in linoleic acid, omega-6) fat (15 E%).

OTHER

SFA diet

Diet high in saturated fat (15E%)

Sponsors & Collaborators

  • Swedish Council for Working Life and Social Research

    collaborator OTHER

  • Uppsala University

    lead OTHER

Principal Investigators

  • Ulf Risérus, PhD · Clinical Nutrition and Metabolism, Dept. of Public Health and Caring Sciences, Uppsala University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-02-28
Primary Completion
2010-04-30
Completion
2010-04-30

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01038102 on ClinicalTrials.gov